Achievements
- Y Combinator S17 alum, Co-founder & CEO of Oncobox
- Developed proprietary AI platforms for gene expression analysis in cancer diagnostics
- Published in top journals like Nature Leukemia, PNAS, Seminars in Oncology
- Oncobox's tech shown to significantly improve cancer treatment responses in clinical trials
- Partnerships with Stanford and Boston University, plus major funding secured
- Named to Forbes 30 under 30
Meet Andrew Garazha
Yo, have you heard about Andrew Garazha? This dude is the real deal in biotech and AI, no cap. He’s a YC alum from S17, so he’s been in the startup game for a minute, and he crushed it. But what’s crazy is his whole process, like, he’s been deep in the science and tech trenches long before launching Oncobox, his big baby.
Andrew’s background is wild. He’s got degrees in biotech and applied math and physics from MIPT, one of Russia’s top schools. Then he jumped into research at places like Caltech and the Federal Clinical Center of Oncology, Immunology, and Hematology. Basically, he’s been mixing hardcore science with startups since way back. He’s published in top journals like Nature Leukemia and PNAS, so the dude isn’t just talk, he’s legit in the research world.
Fast forward, he co-founded Oncobox, and that’s where shit gets interesting. The company is all about using AI to crack cancer diagnostics and personalized treatment plans. Think about it, he developed proprietary platforms that analyze gene expression to help doctors pick the right therapy for each patient. The clinical results? They’re impressive. They’ve shown real improvements in how patients respond to cancer treatments. That’s a big change, no doubt.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herAnd he didn’t just build this tech and dip. Oncobox’s got partnerships with big names like Stanford and Boston University, plus serious funding and grants. He’s based in the Bay Area, surrounded by the best in tech and biotech, which is perfect for scaling something so original. Plus, he’s been recognized as one of Forbes 30 under 30, so the world’s starting to notice what he’s doing.
What does all this say about him? Honestly, it’s about grit and purpose. Here’s a guy who’s been deeply rooted in science and tech from the beginning, driven by a desire to make a real impact, like, save lives kind of impact. He’s not just into startups for the hype; he genuinely wants to push the boundaries of what’s possible in cancer treatment. His process shows he’s all about merging the best of research and real-world application, and he’s not afraid to jump into the deep end.
So yeah, Andrew Garazha isn’t just another founder. He’s one of those rare people who’s been crushing it in academia, research, and startups, and now he’s using all of that to change how we fight cancer. If you ask me, he’s someone to watch, one of those who’s gonna keep pushing the limits and making waves.

Select your comment type:
If something is wrong about Andrew Garazha, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)